During my graduate career at the University of Pittsburgh under Dr. Scott Nelson, and my postdoctoral associate at Harvard University under Dr. David Evans, I worked on complex molecule synthesis with a focus on asymmetric catalysis. After an extremely enlightening and productive decade as a medicinal chemist at Abbvie I transitioned to PostEra where I lead projects focused on Women's Health and antiviral therapies. My focus is on drug discovery using Machine Learning to enhance the Design-Make-Test cycle.